Randomized phase III trial of surgery alone or surgery plus preoperative gemcitabine-cisplatin in clinical early stages (T2N0, T1 - 2N1, T3N0 and T3N1) non-small cell lung cancer (NSCLC)
Latest Information Update: 24 Nov 2016
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms ChEST
- 23 Jun 2008 Status change
- 30 May 2008 Results reported at ASCO 2008.
- 27 Dec 2007 The expected completion date for this trial is now 1 Jun 2015 according to ClinicalTrials.gov.